Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“No Way” FDA Can Require NDI Notifications For All Supplements – McGuffin

This article was originally published in The Tan Sheet

Executive Summary

The leader of the American Herbal Products Association is confident FDA will ultimately require notifications strictly for new dietary ingredients, not all supplements containing those ingredients.

You may also be interested in...



FDA Should Accept Industry’s Grandfathered Ingredient Lists – NPA

FDA Should Accept Industry’s Grandfathered Ingredient Lists – NPA

NDI Guidance Sparks Questions Even From Firms Ready To Comply

FDA’s new dietary ingredient notification draft guidance draws questions even from firms that expect compliance will not require drastic changes in their processes.

Topics

Latest News
UsernamePublicRestriction

Register

PS105304

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel